Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
Healx and Boehringer battle rare neurological diseases
19 December 2019
Cambridge Angels
Healx and Boehringer battle rare neurological diseases
Cambridge Angels
19 December 2019

Healx and Boehringer battle rare neurological diseases

Cambridge Angels
19 December 2019

Source:https://www.businessweekly.co.uk/trade-floor/partnerships-joint-ventures/healx-and-boehringer-battle-rare-neurological-diseases

Newer PostIeso Digital Health to trial online therapy tailored for diabetes patients
Older PostParagraf increases Series A round to £16.2m to accelerate product delivery
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net